OWA
DFTX

Opal Wealth Advisors’s Definium Therapeutics DFTX Stock Holding History

Opal Wealth Advisors’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.8K Buy
+1,101
New +$18.7K ﹤0.01% 597
2024
Q3 		– Sell
-1,101
Closed -$7.94K – 802
2024
Q2 		$7.94K Buy
+1,101
New +$9.63K ﹤0.01% 707

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Opal Wealth Advisors's DFTX Position: Q1 2026 in Review

Opal Wealth Advisors opened a new position in Definium Therapeutics (DFTX) in Q1 2026: 1,101 shares worth $20.8K. The stake represents ﹤0.01% of the portfolio and ranks #597 among its holdings. This is a return to the name: Opal Wealth Advisors previously reported a position in DFTX as recently as Q2 2024.

Opal Wealth Advisors first reported a position in DFTX in Q2 2024 and has held it in 2 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Opal Wealth Advisors held 1,101 shares of Definium Therapeutics worth $20.8K as of Q1 2026.
  • Definium Therapeutics was a new Opal Wealth Advisors position in Q1 2026.
  • Definium Therapeutics made up ﹤0.01% of Opal Wealth Advisors's portfolio in Q1 2026, its #597 holding.
  • Opal Wealth Advisors first reported a position in Definium Therapeutics in Q2 2024 and has held it in 2 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Opal Wealth Advisors's 13F filing for Q1 2026, filed 14 Apr 2026.